UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 20, 2017
U.S. PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)
|
Nevada
|
|
1-11151
|
|
76-0364866
|
|
(State or other jurisdiction
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
1300 West Sam Houston Parkway South,
Suite 300, Houston, Texas
|
|
77042
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant's telephone number, including area code: (713) 297-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events
On March 16, 2017 the Company reported that an accounting error that involved the reporting of redeemable non-controlling interests had caused the Company to be in technical default of the credit agreement with its bank lender.
On March 20, 2017, the bank granted a 30 day forbearance period during which the Company and the bank are in discussions to put into place a permanent amendment to the agreement. The Company may borrow up to an additional $10,000,000 under the credit agreement during this period.
|
Item 9.01
|
FINANCIAL STATEMENTS AND EXHIBITS
|
|
Exhibits
|
|
Description of Exhibits
|
|
|
|
None.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
U.S. PHYSICAL THERAPY, INC.
|
||||
|
Dated: March 20, 2017
|
|
|
By:
|
|
/s/ LAWRANCE W. MCAFEE
|
|
|
|
|
|
Lawrance W. McAfee
|
|||
|
|
|
|
Chief Financial Officer
|
|||
|
|
|
|
(duly authorized officer and principal financial
and accounting officer)
|
|||